heme has been researched along with Intermittent Claudication in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araslanov, SA; Bogachev, VY; Bokuchava, M; Kelimbetov, R; Kuznetsov, MR; Lukyanov, YV; Mzhavanadze, ND; Pang, H; Suchkov, IA | 1 |
| de la Haye, R; Kuntz, G; Rettig, K; Streminski, JA | 1 |
2 trial(s) available for heme and Intermittent Claudication
| Article | Year |
|---|---|
Efficacy and safety of Actovegin in the treatment of intermittent claudication: results of an international, multicenter, placebo-controlled, randomized, phase IIIb clinical trial (APOLLO).
Topics: Heme; Humans; Intermittent Claudication; Peripheral Vascular Diseases; Quality of Life; Walking | 2022 |
[Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
Topics: Adult; Aged; Arterial Occlusive Diseases; Exercise; Female; Heme; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Walking | 1992 |